of plasma exchange may outweigh the benefit; however, in patients with a higher risk of progression to ESRD, the decrease in risk could outweigh the increased risk of serious infection with plasma exchange. Therefore, the Voting Panel does not recommend plasma exchange for all patients with active glomerulonephritis but favors consideration of the treatment for patients at a higher risk of progression to ESRD. Factors that could influence whether plasma exchange is initiated include the